The upcoming APCCC 2019 meeting on advanced prostate cancer

The first iteration of the Advanced Prostate Cancer Consensus Conference (APCCC) was held in St. Gallen, Switzerland, in 2017, and the second iteration is upcoming in late August this year — this time in Basel. … READ MORE …

Vigorous exercise and prostate cancer risk

A new study just published in European Urology appears to have confirmed a connection between regular, vigorous exercise (in men of 45 to 75 years of age) and a reduced risk for aggressive (i.e., advanced and lethal) forms of prostate cancer. … READ MORE …

A rare case of cutaneous, metastatic prostate cancer

Last week we learned of a distinctly unusual case of advanced prostate cancer, and the patient has given us his permission to provide our readers with some specific information about his case. … READ MORE …

Metformin + ADT in treatment of advanced prostate cancer

Yet another study, just published in the Journal of Urology, has indicated a clear association between the use of metformin along with androgen deprivation therapy (ADT) in the treatment of advanced forms of prostate cancer. … READ MORE …

Two leading women talk about the future of treatment of advanced prostate cancer

Nearly 30 years ago, when your sitemaster first attended a prostate cancer meeting (in 1989) related to the upcoming approval of a new drug called flutamide, he doesn’t remember there being a single clinician at the meeting who was female — out of the 150 or so urologists and medical oncologists who had been invited. … READ MORE …

Initial local treatment and long-term survival of men with advanced prostate cancer

We have previously had no really accurate data on a very important question: Does local treatment of men initially diagnosed with advanced prostate cancer impact their long-term survival and mortality rates? … READ MORE …

The Metastatic Prostate Cancer Project: listen to the program

Yesterday evening we were pleased to be able to collaborate with CureTalks to host a conversation with Dr. Eli Van Allen — the principal investigator for the Metastatic Prostate Cancer Project — to “spread the word” about this initiative. … READ MORE …